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ABSTRACT 
Photoacoustic tomography provides both structural and functional imaging in vivo based on optical absorption contrast. 
A novel imaging system that incorporates a two-dimensional matrix ultrasound probe for combined photoacoustic and 
ultrasonic three-dimensional (3D) volumetric imaging is presented. The system consists of a tunable dye laser pumped 
by a Nd:YAG laser, a commercial ultrasound imaging system (Philips iU22) with a two-dimensional matrix transducer 
(Philips X7-2, 2500 elements, 2-7 MHz), and a multichannel data acquisition system which allows us to acquire RF 
channel data. Compared with alternative 3D techniques, this system is attractive because it can generate co-registered 3D 
photoacoustic and ultrasound images without mechanical scanning. Moreover, the lateral resolution along the azimuth 
and elevational directions are measured to be 0.77 ± 0.06 mm and 0.96 ± 0.06 mm, respectively, based on reconstructed 
photoacoustic images of phantoms containing individual human hairs. Finally, in vivo 3D photoacoustic sentinel lymph 
node mapping using methylene blue dye in a rat model is demonstrated. 
Keywords: photoacoustic imaging, ultrasound, matrix ultrasound transducer, three-dimensional imaging, sentinel lymph 
node 
1. INTRODUCTION 
Photoacoustic imaging is a promising technology that combines image contrast based on optical absorption with 
ultrasonic resolution. The basis for photoacoustic wave generation is optical absorption by tissue structures that are 
illuminated by short pulses of light. Under stress and thermal confinement conditions, transient heating induces 
thermoelastic expansion and emission of acoustic pressure waves. These photoacoustic waves can be detected by 
conventional ultrasound array transducers for image reconstruction. Photoacoustic imaging overcomes the depth 
limitations of pure optical imaging techniques by utilizing ultrasonic detection, since acoustic scattering is 2-3 orders of 
magnitude less than optical scattering. It is capable of high-resolution structural, functional, and molecular imaging free 
from speckle artifacts.1 
Recently, efforts have been made to incorporate two-dimensional (2D) array transducers for efficient three-dimensional 
(3D) photoacoustic imaging. Specifically, a 2D capacitive micromachined ultrasonic transducer (CMUT) with 16 x 16 
transducer elements has been developed for photoacoustic and ultrasonic imaging.2 Mechanical scanning was used to 
simulate a larger 64 x64 element aperture for improved image quality. In addition, a 1.75D array transducer with 1280 
elements (10 x 128) was constructed for ultrasonic and photoacoustic characterization of ex vivo ovarian tissue.3 Also, a 
polyvinylidene fluoride (PVDF) matrix array hydrophone with 590 transducer elements was used as a photoacoustic 
receiver in a research prototype system for breast cancer detection.4, 5 The advantage of 2D arrays is that 3D images can 
be acquired without mechanical scanning and, by using a small number of laser firings, achieve higher imaging frame 
rates than other systems. The trade-off is increased system complexity to manage data from a larger number of 
transducer elements. 
A promising clinical application of photoacoustic imaging is for noninvasive sentinel lymph node mapping. Sentinel 
lymph nodes are the first nodes to receive drainage from the tumor, and as such, are most likely to contain metastatic 
tumor cells. Biopsy of sentinel lymph nodes is an effective method to determine if the cancer has spread beyond the 
primary tumor into the lymphatic system. Sentinel lymph node biopsy is critical for cancer staging to plan appropriate  
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therapy and evaluate prognosis, and has become the standard of care for axillary staging in newly diagnosed breast  
cancer patients.6-8 The current method of sentinel lymph node biopsy depends on local injection of blue dyes and 
radioactive tracers that accumulate in sentinel nodes. Surgeons use incisions to invasively locate and excise sentinel 
nodes based on visual inspection for blue nodes and using Geiger counters to detect radioactive nodes. Excised nodes 
undergo pathological examination to determine the presence of metastases. A noninvasive method for sentinel lymph 
node identification could enable percutaneous needle biopsies as a viable option for axillary staging of breast cancer 
patients. The same blue dyes (i.e. methylene blue) currently used in clinical practice for sentinel lymph node biopsy can 
serve as photoacoustic contrast agents due to strong optical absorption by the dye. In vivo preclinical experiments in a 
rat model have successfully demonstrated noninvasive photoacoustic imaging of sentinel lymph nodes following 
injection of methylene blue,9 indocyanine green,10 gold nanoparticles,11, 12 and carbon nanotubes.13 A modified clinical 
ultrasound system capable of photoacoustic imaging has highlighted the potential for clinical translation of 
photoacoustic sentinel lymph node mapping.14-16 
In this report, the modified clinical ultrasound system has been extended to enable 3D photoacoustic and ultrasound 
imaging using a 2D matrix array transducer. This is the first time to our knowledge that 3D photoacoustic imaging has 
been demonstrated using a clinical 2D matrix array ultrasound transducer. The performance of this multi-modal 3D 
imaging system has been evaluated using resolution phantoms and for in vivo sentinel lymph node mapping. 
2. METHODOLOGY 
2.1 Photoacoustic imaging system 
A prototype photoacoustic imaging system (Figure 1) has been built around a Philips iU22 ultrasound scanner (Philips 
Healthcare, Andover, MA).14-16 The modified channel board architecture allowed access to raw per-channel 
photoacoustic RF data, while retaining all imaging capabilities of an actual commercial ultrasound scanner. Raw 
photoacoustic and ultrasound RF data were transferred to a custom-built data acquisition system for post-processing 
image reconstruction, providing dual-modality imaging capability. The 2D matrix array probe X7-2 (2500 elements) 
with nominal bandwidth 2-7 MHz was used for 3D photoacoustic and ultrasound imaging. Currently, one photoacoustic 
volume image is generated from 36 lasers shots, requiring 20 seconds for data acquisition followed by offline image 
reconstruction using a 3D delay and sum beamforming algorithm implemented in Matlab (MathWorks Inc., Natick, 
MA). An FPGA-based electronic board and separate delay generator (Stanford Research Systems, Sunnyvale, CA) 
synchronized iU22 data acquisition with laser firings. The X7-2 transducer performs micro-beamforming within the 
transducer to reduce the number of system channels needed for the large number of transducer elements. The micro-
beamforming process performed within the transducer is reversed offline using a novel, proprietary algorithm to recover 
raw photoacoustic channel data. Photoacoustic maximum amplitude projection (MAP) images were reconstructed by 
first removing the skin signal and then projecting the remaining maximum signal amplitude along each A-line onto the 
corresponding x - y plane. Volumetric photoacoustic images were visualized by using VolView software (Kitware, 
Clifton Park, NY). 
Light from a tunable dye laser (PrecisionScan-P, Sirah,  Kaarst, Germany), pumped by a Q-switched Nd:YAG laser 
(PRO-350-10, Spectra-Physics, Santa Clara, CA) with 6.5-ns pulse duration and 10-Hz pulse repetition rate, was 
delivered via a fused end, bifurcated fiber bundle (LightGuideOptics, Rheinbach, Germany). Photoacoustic images were 
acquired using 650 nm light, which is close to the peak absorption wavelength for methylene blue dye. The light fluence 
on the skin was less than 10 mJ/cm2, within American National Standards Institute safety limits.17 
The fiber bundles were mounted to the matrix array probe to enable dual-modality 3D photoacoustic and ultrasonic 
imaging without mechanical scanning. The ultrasound probe was partially immersed in a water tank which had an 
opening at the bottom sealed with a thin, disposable, clear membrane. Rats were placed below the water tank, in contact 
with the membrane via ultrasonic coupling gel. 
2.2 Resolution phantom preparation 
To investigate the spatial resolution of the matrix probe, we imaged human hairs embedded within a gelatin phantom. A 
hot gelatin water solution (10% by weight) was made and congealed in mold. Two hairs were placed on top and another 
layer of gelatin was poured, completely covering the hairs. The gelatin phantom was placed in a water bath with the 
ultrasound transducer positioned 2 cm above the hairs.   
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2.3 Animal and dye preparation 
Animal protocols were approved by the Washington University Animal Studies Committee and animal handling was 
performed according to the guidelines on the care and use of laboratory animals. Healthy Sprague Dawley rats (N = 3) 
were anesthetized using a mixture of ketamine (85 mg/kg) and xylazine (15 mg/kg). The hair in the left axillary region 
was gently depilated before imaging. Photoacoustic and ultrasound images were collected before and after 100 μL 
intradermal injection of 1% methylene blue dye (10 mg/mL, American Reget, Inc., Shirley, NY) into the left forepaw 
pad. Photoacoustic images were collected at 5 minute intervals for up to 30 minutes post-injection, with an additional 
time point collected at 2.5 min post-injection. After imaging, animals were euthanized with an overdose of pentobarbital, 
and SLNs were dissected. 
 
Figure 1. Experimental setup of the 3D photoacoustic imaging system adapted from a modified Philips iU22 
ultrasound (US) imaging system (Philips Healthcare, Andover, MA). 
3. RESULTS 
3.1 Resolution phantom imaging 
Photoacoustic images of two human hairs embedded within a gelatin phantom yield estimates of the spatial resolution of 
the matrix array transducer (Fig. 2). Figure 2a-b display photoacoustic maximum amplitude projection (MAP) images of 
the two hairs positioned along the azimuth and elevation direction, respectively. Figure 2c displays a photoacoustic B-
mode image of the two hairs positioned along the elevation direction. Figure 2d-f show corresponding 1D line profiles as 
indicated by the dashed lines in Fig. 2a-c, respectively. Based on the measured full-width at half-maximum (FWHM) 
signal profiles, the average lateral resolutions along the azimuth and elevation directions are 0.77 ± 0.06 mm and 0.96 ± 
0.06 mm, respectively. The average axial resolution is 1.02 ± 0.15 mm.  
3.2 In vivo 3D photoacoustic SLN mapping 
Photoacoustic imaging with the matrix array transducer has been successfully demonstrated in vivo for 3D SLN 
mapping (Fig. 3). Photoacoustic MAP images show the accumulation of methylene blue dye in a rat SLN at 0, 5, and 30 
minutes post-injection (Fig. 3 b, c, d). The 0 minute time point was acquired immediately following methylene blue 
injection and shows a substantial increase in the mean photoacoustic signal amplitude from the SLN region compared 
with the control photoacoustic MAP image acquired prior to methylene blue injection (Fig. 3a). This signal increase 
reflects the rapid collection of methylene blue by lymphatic vessels in the rat forepaw and subsequent accumulation in 
the SLN. Since the methylene blue injection lasted about 10 seconds and 3D data acquisition took 20 seconds, the 0 
minute time point consists of photoacoustic signals received up to 30 seconds after the start of the injection. 
The dynamic increase in photoacoustic signal amplitudes from SLN regions following methylene blue injection is 
displayed according to mean and standard deviation (Fig. 3e). Photoacoustic signal amplitudes are plotted relative  
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Figure 2. Photoacoustic images of two human hairs embedded within a clear gelatin phantom. (a) Photoacoustic 
maximum amplitude projection (MAP) image of hairs positioned along azimuth direction. (b) Photoacoustic MAP 
image of hairs positioned along elevation direction. (c) Photoacoustic B-mode image of hairs positioned along 
elevation direction. (d, e, f) 1D profiles along the dashed lines depicted in (a), (b), and (c), respectively. 
 
Figure 3. Noninvasive photoacoustic images of rat axillary region. (a) Control photoacoustic maximum amplitude 
projection (MAP) image collected prior to methylene blue injection into the rat forepaw. (b,c,d) Photoacoustic 
MAP images collected 0, 5, and 30 minutes following methylene blue injection, respectively, showing 
photoacoustic signal enhancement at the sentinel lymph node (SLN). (f) Graph shows dynamic changes in 
photoacoustic signal amplitudes from SLN. (f) Postmortem photograph of rat acquired after photoacoustic 
imaging and skin removal. 
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to the pre-injection signal amplitude from the same region-of-interest. Photoacoustic signal amplitudes at 30 minutes 
post-injection increase approximately 20 times compared to the pre-injection baseline signal amplitudes, illustrating the 
strong contrast enhancement provided by methylene blue. The dynamics of methylene blue accumulation in a rat lymph 
node represented by the photoacoustic signal amplitude is consistent with previous reports, reaching peak signal 
amplitudes at 20-30 minutes post-injection.14 The accumulation of methylene blue dye in the rat SLN was confirmed by 
postmortem dissection (Fig. 3f). 
Co-registered 3D photoacoustic and ultrasound images depict functional, represented by methylene blue accumulation, 
and structural information, represented by morphological features (Fig. 4). The location of the sentinel lymph node 
relative to the surrounding anatomy can be best appreciated in co-registered 3D photoacoustic and ultrasound images. 
Figure 4a illustrates a co-registered volume image with the indicated 2D B-mode slice depicted in Fig. 4b. 
 
Figure 4. (a) Co-registered, in vivo 3D photoacoustic and ultrasound image acquired 30 minutes following 
methylene blue injection. (b) Co-registered photoacoustic and ultrasound B-mode image of rat sentinel lymph 
node (SLN). Photoacoustic signals are overlaid using a pseudo-color map. 
4. DISCUSSION 
A modified clinical ultrasound system has been adapted for 3D photoacoustic imaging using a 2D matrix array 
transducer. The addition of 3D photoacoustic imaging to this system provides an additional contrast mechanism based on 
optical absorption. The current system acquires a complete 3D photoacoustic dataset in 20 seconds from 36 laser firings 
and performs offline image reconstruction of a 4 x 4 x 5 cm3 volume. Compared to previous photoacoustic imaging 
systems developed around 2D matrix array transducers,2-5 this system offers fast photoacoustic data acquisition, sub-
millimeter spatial resolution, and incorporates the full 3D ultrasound imaging functionality offered by the commercial 
iU22 system. The 3D ultrasound modes currently available on the system include live 3D imaging and live biplane 
imaging for real-time display of two planes simultaneously. Further system development could reduce the number of 
laser firings required and produce a photoacoustic volume image in real-time at a reasonable frame rate. Faster imaging 
frame rates will enable hand-held scanning, which is needed to fully realize the potential of 3D photoacoustic imaging 
with 2D matrix array transducers. The feasibility of 3D photoacoustic imaging using a modified clinical ultrasound 
imaging system has been established, which represents an important development towards this goal. 
The results demonstrate the utility of the current system for dynamic 3D photoacoustic imaging in vivo. 3D 
photoacoustic images show the accumulation of methylene blue dye within a rat sentinel lymph node in the first 30 
minutes following dye injection. Strong photoacoustic contrast enhancement (~20x) resulted from methylene blue 
accumulation in the rat lymph node, which highlights the potential of this clinically-used dye. 3D photoacoustic imaging 
could offer unique clinical advantages for improved visualization of multiple sentinel nodes, as typically 1-3 nodes are 
removed during sentinel lymph node biopsy. Finally, percutaneous needle biopsies of sentinel lymph nodes could be 
guided more efficiently by 3D photoacoustic and ultrasound imaging than by 2D imaging alone.15, 18, 19 
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